C1ORF131 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.326600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.781600E-01
Normal-vs-Stage2
7.652400E-01
Normal-vs-Stage3
1.268440E-01
Normal-vs-Stage4
9.687200E-01
Stage1-vs-Stage2
3.299600E-01
Stage1-vs-Stage3
1.390570E-01
Stage1-vs-Stage4
7.251200E-01
Stage2-vs-Stage3
1.614030E-01
Stage2-vs-Stage4
7.672600E-01
Stage3-vs-Stage4
1.205770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.990800E-01
Normal-vs-AfricanAmerican
6.180600E-01
Normal-vs-Asian
9.189400E-01
Caucasian-vs-AfricanAmerican
3.112400E-01
Caucasian-vs-Asian
6.124000E-01
AfricanAmerican-vs-Asian
5.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.213400E-01
Normal-vs-Female
6.030000E-01
Male-vs-Female
4.309400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.190400E-01
Normal-vs-Age(41-60Yrs)
5.495400E-01
Normal-vs-Age(61-80Yrs)
7.683600E-01
Normal-vs-Age(81-100Yrs)
8.739200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.842000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.269600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.769400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.621200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.234000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.520000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.746600E-01
Normal-vs-Daily Drinker
2.337400E-01
Normal-vs-Weekly Drinker
6.648600E-01
Normal-vs-Occasional Drinker
7.375200E-01
Normal-vs-Social Drinker
9.713400E-01
Non Drinker-vs-Daily Drinker
1.270250E-01
Non Drinker-vs-Weekly Drinker
8.522200E-01
Non Drinker-vs-Occasional Drinker
6.916200E-01
Non Drinker-vs-Social Drinker
4.198400E-01
Daily Drinker-vs-Weekly Drinker
3.130600E-01
Daily Drinker-vs-Occasional Drinker
4.854000E-02
Daily Drinker-vs-Social Drinker
5.338100E-02
Weekly Drinker-vs-Occasional Drinker
6.332200E-01
Weekly Drinker-vs-Social Drinker
4.479000E-01
Occasional Drinker-vs-Social Drinker
6.314400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.129990E-01
Normal-vs-Grade 2
2.167700E-02
Normal-vs-Grade 3
4.799800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.616400E-01
Grade 1-vs-Grade 3
3.793400E-01
Grade 1-vs-Grade 4
1.129990E-01
Grade 2-vs-Grade 3
8.190800E-01
Grade 2-vs-Grade 4
2.167700E-02
Grade 3-vs-Grade 4
4.799800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.162000E-01
Normal-vs-NonDiabetic
6.539400E-01
Diabetic-vs-NonDiabetic
3.711600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.454800E-01
Normal-vs-NoPancreatitis
6.627600E-01
Pancreatitis-vs-NoPancreatitis
2.901200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.109600E-01
Normal-vs-N1
6.833800E-01
N0-vs-N1
3.858800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.349000E-01
Normal-vs-TP53-NonMutant
8.326600E-01
TP53-Mutant-vs-TP53-NonMutant
8.244000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
